Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase IV Study: A Prospective Two-Site Study to Evaluate the Safety and Tolerance of Besivance Versus Vigamox Prophylactically Pre and Post Operatively in Subjects Undergoing Routine Cataract Surgery

NCT01455233 is registered in ClinicalTrials.gov with Ophthalmology Consultants, Ltd. as lead sponsor.

NCT NCT01455233
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01455233 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase IV Study: A Prospective Two-Site Study to Evaluate the Safety and Tolerance of Besivance Versus Vigamox Prophylactically Pre and Post Operatively in Subjects Undergoing Routine Cataract Surgery
Lead sponsor
Ophthalmology Consultants, Ltd.
Phase
Phase 4
Overall status
Completed
Start date
September 30, 2010
Completion date
February 28, 2011
Enrollment
60 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cataract surgery, corneal health